News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,666 Results
Type
Article (87566)
Company Profile (827)
Press Release (775253)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233114)
Career Advice (4140)
Deals (39817)
Drug Delivery (141)
Drug Development (91293)
Employer Resources (203)
FDA (18303)
Job Trends (17407)
News (397521)
Policy (39932)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (133)
Alliances (56980)
ALS (147)
Alzheimer's disease (1695)
Antibody-drug conjugate (ADC) (269)
Approvals (18344)
Artificial intelligence (522)
Autoimmune disease (110)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (533)
Cancer (4238)
Cardiovascular disease (379)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (717)
Cervical cancer (33)
Clinical research (75957)
Collaboration (1462)
Company closure (4)
Compensation (983)
Complete response letters (64)
COVID-19 (2966)
CRISPR (87)
C-suite (632)
Cystic fibrosis (142)
Data (5117)
Decentralized trials (2)
Denatured (65)
Depression (116)
Diabetes (472)
Diagnostics (7117)
Digital health (39)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (249)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99509)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133712)
Executive appointments (1000)
FDA (20916)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (18)
Funding (1313)
Gene editing (185)
Generative AI (52)
Gene therapy (576)
GLP-1 (1050)
Government (5398)
Grass and pollen (8)
Guidances (375)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (75)
Immunology and inflammation (263)
Immuno-oncology (22)
Indications (61)
Infectious disease (3220)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17933)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (644)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (13)
Lung cancer (600)
Lymphoma (290)
Machine learning (33)
Management (66)
Manufacturing (676)
MASH (152)
Medical device (14918)
Medtech (14947)
Mergers & acquisitions (22806)
Metabolic disorders (1221)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (240)
Neuropsychiatric disorders (64)
Neuroscience (2783)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (587)
Opinion (317)
Ovarian cancer (146)
Pain (173)
Pancreatic cancer (183)
Parkinson's disease (248)
Partnered (32)
Patents (435)
Patient recruitment (346)
Peanut (57)
People (66382)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23429)
Phase II (32959)
Phase III (24857)
Pipeline (3078)
Policy (306)
Postmarket research (3554)
Preclinical (10592)
Press Release (72)
Prostate cancer (207)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (718)
Real estate (7424)
Recruiting (79)
Regulatory (28176)
Reports (65)
Research institute (2700)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1071)
Venture capital (69)
Weight loss (414)
Women's health (64)
Worklife (21)
Date
Today (249)
Last 7 days (1279)
Last 30 days (3565)
Last 365 days (33641)
2025 (29202)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51105)
Australia (8983)
California (10115)
Canada (2968)
China (967)
Colorado (422)
Connecticut (447)
Delaware (290)
Europe (117497)
Florida (1480)
Georgia (327)
Hawaii (3)
Idaho (67)
Illinois (835)
India (56)
Indiana (494)
Iowa (20)
Japan (340)
Kansas (127)
Kentucky (39)
Louisiana (27)
Maine (80)
Maryland (1341)
Massachusetts (7550)
Michigan (322)
Minnesota (594)
Mississippi (4)
Missouri (126)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (81)
New Jersey (2785)
New Mexico (32)
New York (2705)
North Carolina (1463)
North Dakota (10)
Northern California (4694)
Ohio (311)
Oklahoma (22)
Oregon (51)
Pennsylvania (2075)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3853)
Tennessee (153)
Texas (1572)
United States (36988)
Utah (301)
Virginia (258)
Washington D.C. (84)
Washington State (856)
West Virginia (4)
Wisconsin (105)
Wyoming (2)
There are 863,666 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
November 10, 2025
·
3 min read
Press Releases
Onward Therapeutics Completes Share Exchange and Establishes Global Headquarters in Taiwan
November 10, 2025
·
3 min read
Press Releases
Belenos Pipeline Updates: First Clinical Data from Lead Asset BEL512, a Long-lasting Bispecific Targeting TSLP and IL-13, Second Asset BEL336, a First-in-class Long-acting Bispecific Targeting OX40L and IL-13, Phase 1 to Start 1Q2026
November 10, 2025
·
3 min read
Press Releases
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
November 10, 2025
·
14 min read
Press Releases
Octave Bioscience to Participate in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2025
·
1 min read
Press Releases
Xencor to Participate at Upcoming Investor Conferences - November 10, 2025
November 10, 2025
·
1 min read
Press Releases
Quanterix Releases Financial Results for the Third Quarter of 2025
November 10, 2025
·
18 min read
Press Releases
Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 10, 2025
·
8 min read
Press Releases
Myomo Reports Third Quarter 2025 Financial and Operating Results
November 10, 2025
·
16 min read
Press Releases
Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
November 10, 2025
·
4 min read
1 of 86,367
Next
